References
- Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472–80
- Enzinger FM. Clear-cell sarcoma of the tendons and aponeuroses: An analysis of 21 cases. Cancer 1965; 18: 1163–74
- Meis-Kindlom JM. Clear cell sarcoma of tendons and aponeuroses: A historical perspective and tribute to the man behind the entity. Adv Anat Pathol 2006; 13: 282–92
- Epstein AL, Martin AO, Kempson R. Use of a newly established human cell line (SU-CCS-1) to demonstrate the relationship of clear cell sarcoma to malignant melanoma. Cancer Res 1984; 44: 1265–74
- Granter S, Weilbaecher K, Quigley C, Fletcher C, Fisher D. Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: Further evidence for melanocytic differentiation. Mod Pathol 2001; 14: 6–9
- Kindblom L, Lodding P, Angervall L. Clear-cell sarcoma of tendons and aponeuroses: An immunohistochemical and electron microscopic analysis indicating neural crest origin. Virchows Arch 1983; 401: 109–28
- d'Amore ESG, Ninfo V. Clear cell tumors of the somatic soft tissues: Sem Diagn Pathol 1997; 14: 270–80
- Langezaal SM, Graadt Van Roggen JF, Cleton-Jansen AM, Baeide JJ, Hogendoorn PCW. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer 2001; 84: 535–8
- Nedoszytko B, Mrózek K, Roszkiewicz A, Kopacz A, Swierblewśki M, Limon J. Clear cell sarcoma of tendons and aponeuroses with t (12;22) (q13;q12) diagnosed initially as malignant melanoma. Cancer Genet Cytogenet 1996; 91: 37–9
- Reeves BR, Fletcher CDM, Gusterson BA. Translocation t(12;22) (q13;q13) is a nonrandom rearrangement in clear cell sarcoma. Cancer Genet Cytogenet 1992; 64: 101–3
- Speleman F, Delattre O, Peter M, Hauben E, Van Roy N, Van Marck E. Malignant melanoma of the soft parts (clear-cell sarcoma): Confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation. Mod Pathol 1997; 10: 496–9
- Stenman G, Kindblom LG, Angervall L. Reciprocal translocation t(12;22) (q13;q13) in clear-cell sarcoma of tendons and aponeuroses. Genes Chromosomes Cancer 1992; 4: 122–7
- Bosilevac JM, Olsen RJ, Bridge JA, Hinrichs S. Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein. J Biol Chem 1999; 274: 34811–8
- Fujimura Y, Ohno T, Siddique H, Lee L, Rao VN, Reddy EP. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. Oncogene 1996; 12: 159–67
- Lauro S, Bordin F, Trasatti, Lanzetta G, Della Rocca C, Frati L. Concurrent chemoimmunotherapy in metastatic clear cell sarcoma: A case report. Tumori 1999; 85: 512–4
- Steger GG, Wrba F, Mader R, Schlappack O, Dittrich C, Rainer H. Complete remission of metastasised clear cell sarcoma of tendons and aponeuroses. Eur J Cancer 1991; 27: 254–6
- Anderson C, Buzaid A, Legha S. Systemic treatments for advanced cutaneous melanoma. Oncology 1995; 9: 1149–58